171
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Increased Tear Film Osmolarity in Systemic Lupus Erythematosus

, , , , , , & show all
Pages 582-587 | Received 16 Oct 2015, Accepted 27 Nov 2015, Published online: 18 May 2016

REFERENCES

  • Tikly M, Navarra SV. Lupus in the developing world: Is it any different? Best Pract Res Clin Rheumatol. 2008;22:643–655.
  • Jensen JL, Bergem HO, Gilboe IM, Husby G, Axell T. Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus. J Oral Pathol Med. 1999;28:317–322.
  • Read RW. Clinical mini-review: Systemic lupus erythematosus and the eye. Ocul Immunol Inflamm. 2004;12:87–99.
  • The definition and classification of dry eye disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf. 2007;52:75–92.
  • Mathers WD. Why the eye becomes dry: A cornea and lacrimal gland feedback model. CLAO J. 2000;263:159–165.
  • Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res. 2010;35:553–564.
  • Lemp MA, Bron AJ, Baudouin C, Benítez Del Castillo JM, Geffen D, Tauber J, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792–798.
  • Benelli U, Nardi M, Posarelli C, Albert TG. Tear osmolarity measurement using the TearLabTM Osmolarity System in the assessment of dry eye treatment effectiveness. Cont Lens Anterior Eye 2010;33:61–67.
  • Bunya VY, Langelier N, Chen S, Pistilli M, Vivino FB, Massaro-Giordano G. Tear osmolarity in Sjögren syndrome. Cornea 2013;32:922–927.
  • Utine CA, Bıçakçıgil M, Yavuz S, Çiftçi F. Tear osmolarity measurements in dry eye related to primary Sjögren’s syndrome. Curr Eye Res. 2011;36:683–690.
  • Szalai E, Berta A, Szekanecz Z, Szûcs G, Módis L Jr. Evaluation of tear osmolarity in non-Sjögren and Sjögren syndrome dry eye patients with the TearLab system. Cornea 2012;31:867–871.
  • Srinivasan S, Joyce E, Jones LW. Tear osmolality and ferning patterns in postmenopausal women women. Optom Vis Sci. 2007;84:588–592.
  • Gayton JL. Etiology, prevalence, and treatment of dry eye disease. Clin Ophthalmol. 2009;3:405–412.
  • Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277.
  • Farris RL, Stuchell RN, Mandel ID. Tear osmolarity variation in the dry eye. Trans Am Ophthalmol Soc. 1986;84:250–268.
  • Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–621.
  • Schaumberg DA, Gulati A, Mathers WD, Clinch T, Lemp MA, Nelson JD, et al. Development and validation of a short global dry eye symptom index. Ocul Surf. 2007; 5:50–57.
  • Nichols JJ, Sinnott LT. Tear film, contact lens, and patient-related factors associated with contact lens-related dry eye. Investig Ophthalmol Vis Sci. 2006;47:1319–1328.
  • Tomlinson A, McCann LC, Pearce El. Comparison of human tear film osmolarity measured by electrical impedance and freezing point depression techniques. Cornea 2010;29:1036–41.
  • Gilbard JP. Dry eye, blepharitis and chronic eye irritation: Divide and conquer. J Ophthalmic Nurs Technol. 1999;18:109–115.
  • Gilbard JP, Carter JB, Sang DN, Refojo MF, Hanninen LA, Kenyon KR. Morphologic effect of hyperosmolarity on rabbit corneal epithelium. Ophthalmology 1984;91:1205–1212.
  • Gilbard JP, Rossi SR, Gray KL. A new rabbit model for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 1987;28:225–228.
  • Gilbard JP, Rossi SR, Gray KL, Hanninen LA, Kenyon KR. Tear film osmolarity and ocular surface disease in two rabbit models for keratoconjunctivitis sicca. Invest Ophthalmol Vis Sci. 1988;29:374–378.
  • Li DQ, Chen Z, Song XJ, Luo L, Pflugfelder SC. Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells. Invest Ophthalmol Vis Sci. 2004;45:4302–4311.
  • Li DQ, Luo L, Chen Z, Kim HS, Song XJ, Pflugfelder SC. JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stres in human limbal epithelial cells. Exp Eye Res. 2006;82:588–596.
  • Tomlinson A, Khanal S, Ramaesh K, Diaper C, McFadyen A. Tear film osmolarity: Determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci. 2006;47:4309–4315.
  • Farris RL. Tear osmolarity—a new gold standard? Adv Exp Med Biol. 1994;350:495–503.
  • Sullivan BD, Whitmer D, Nichols KK, Tomlinson A, Foulks GN, Geerling G, et al. An objective approach to dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:6125–6130.
  • Türkyilmaz K, Küçükali Türkyilmaz A, Kurt A, Kurt EE, Sevim MŞ, Oner V. Investigation of tear osmolarity in early rheumatoid arthritis: Relation to disease activity. Can J Ophthalmol. 2013;48:235–239.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren’s syndrome: A revised version of the European criteria proposed by theAmerican-European Consensus Group. Ann Rheum Dis. 2002;61:554–558.
  • Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: Lactoplate, Schirmer, and tear osmolarity. CLAO J. 1990; 16:109–112.
  • Cedarstaff TH, Tomlinson A. Human tear volume, quality, and evaporation: A comparison of Schirmer, tear break-up time, and resistance hygrometry techniques. Ophthalmic Physiol Opt. 1983;3:239–245.
  • Versura P, Frigato M, Cellini M, Mulè R, Malavolta N, Campos EC. Diagnostic performance of tear function tests in Sjogren’s syndrome patients. Eye (Lond). 2007; 21:229–237.
  • Moore JE, Vasey GT, Dartt DA, McGilligan VE, Atkinson SD, Grills C, et al. Effect of tear hyperosmolarity and signs of clinical ocular surface pathology upon conjunctival goblet cell function in the human ocular surface. Invest Ophthalmol Vis Sci. 2011;52:6174–6180.
  • Khanal S, Tomlinson A, McFadyen A, Diaper C, Ramaesh K. Dry eye diagnosis. Invest Ophthalmol Vis Sci. 2008;49:1407–1414.
  • Gilbard JP, Farris RL, Santamaria J 2nd. Osmolarity of tear microvolumes in keratoconjunctivitis sicca. Arch Ophthalmol. 1978;96:677–681.
  • Tishler M, Yaron I, Geyer O, Shirazi I, Naftaliev E, Yaron M. Elevated tear interleukin-6 levels in patients with Sjögren’ syndrome. Ophthalmology 1998;105:2327–2329.
  • Suzuki M, Massingale ML, Ye F, Godbold J, Elfassy T, Vallabhajosyula M, et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest Ophthalmol Vis Sci. 2010;51:4557–4561.
  • Fuerst N, Langelier N, Massaro-Giordano M, Pistilli M, Stasi K, Burns C, et al. Tear osmolarity and dry eye symptoms in diabetics. Clin Ophthalmol. 2014;8:507–515.
  • Khanal S, Millar TJ. Barriers to clinical uptake of tear osmolarity measurements. Br J Ophthalmol. 2012;96:341–344.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.